Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$336M |
| 2 |
Truist Financial
TFC
|
+$144M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$103M |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$91.6M |
| 5 |
Home Depot
HD
|
+$90.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$323M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$136M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$56.6M |
| 4 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$41.5M |
| 5 |
VSM
Versum Materials, Inc.
VSM
|
+$39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.04% |
| 2 | Financials | 14.33% |
| 3 | Healthcare | 12.99% |
| 4 | Industrials | 10.19% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MPX
2726
DELISTED
Marine Products Corp
MPX
| $649K | ﹤0.01% |
45,032
+436
| +1% | +$6.31K |
|
|
CNBKA
2727
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $648K | ﹤0.01% |
7,193
-1,365
| -16% | -$119K |
|
2728
Oppenheimer Holdings
OPY
$1.22B
| $644K | ﹤0.01% |
23,426
| – | – |
|
|
ENZ
2729
DELISTED
Enzo Biochem, Inc.
ENZ
| $644K | ﹤0.01% |
244,603
+2,679
| +1% | +$8K |
|
|
MTEM
2730
DELISTED
Molecular Templates, Inc.
MTEM
| $640K | ﹤0.01% |
3,048
+129
| +4% | +$18.5K |
|
2731
BayCom
BCML
$338M
| $637K | ﹤0.01% |
28,009
+2,891
| +12% | +$63.9K |
|
|
LAND
2732
Gladstone Land Corp
LAND
$354M
| $634K | ﹤0.01% |
48,809
+5,822
| +14% | +$71.5K |
|
2733
ACNB Corp
ACNB
$650M
| $632K | ﹤0.01% |
16,693
| – | – |
|
2734
Northrim BanCorp
NRIM
$596M
| $632K | ﹤0.01% |
65,968
| – | – |
|
2735
Ooma
OOMA
$579M
| $631K | ﹤0.01% |
47,681
+1,925
| +4% | +$23.4K |
|
|
CMRX
2736
DELISTED
Chimerix, Inc.
CMRX
| $630K | ﹤0.01% |
310,267
+47,738
| +18% | +$88K |
|
2737
Intrepid Potash
IPI
$498M
| $629K | ﹤0.01% |
23,183
+726
| +3% | +$19.7K |
|
2738
ImmunityBio
IBRX
$8.04B
| $625K | ﹤0.01% |
164,703
+37,660
| +30% | +$64.1K |
|
|
ACOR
2739
DELISTED
Acorda Therapeutics
ACOR
| $624K | ﹤0.01% |
2,545
+406
| +19% | +$102K |
|
2740
Crawford & Co Class B
CRD.B
$594M
| $623K | ﹤0.01% |
61,329
-6,475
| -10% | -$63.6K |
|
2741
Comscore
SCOR
$110M
| $623K | ﹤0.01% |
6,299
+273
| +5% | +$18.7K |
|
2742
Korro Bio
KRRO
$199M
| $620K | ﹤0.01% |
+706
| New | +$549K |
|
2743
Distribution Solutions Group
DSGR
$1.62B
| $618K | ﹤0.01% |
23,700
-2,842
| -11% | -$67.2K |
|
|
RPT
2744
Rithm Property Trust
RPT
$98.2M
| $618K | ﹤0.01% |
7,195
+252
| +4% | +$22.4K |
|
|
GBL
2745
DELISTED
GAMCO Investors, Inc.
GBL
| $618K | ﹤0.01% |
31,659
+330
| +1% | +$5.82K |
|
2746
eGain
EGAN
$202M
| $617K | ﹤0.01% |
77,809
-22,700
| -23% | -$176K |
|
2747
Hurco Companies Inc
HURC
$142M
| $611K | ﹤0.01% |
15,907
+862
| +6% | +$30.3K |
|
|
CHMI
2748
Cherry Hill Mortgage Investment Corp
CHMI
$107M
| $608K | ﹤0.01% |
41,614
+2,582
| +7% | +$36.1K |
|
2749
Evolus
EOLS
$542M
| $607K | ﹤0.01% |
49,809
+15,028
| +43% | +$212K |
|
2750
AMES National
ATLO
$278M
| $606K | ﹤0.01% |
21,595
+792
| +4% | +$22K |
|
Similar funds
Charles Schwab's Q4 2019 Portfolio in Review
As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
- Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
- Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
- Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
- Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
- Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
- Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.
Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.